What Is Ga-68 PSMA PET/CT? Why Is It Used in Prostate Cancer?
Many patients diagnosed with prostate cancer encounter a type of imaging study they may never have heard of before during treatment planning:
Ga-68 PSMA PET/CT (Gallium-68 PSMA PET/CT)
Some of the most common questions patients ask include:
- What is a Ga-68 PSMA PET scan?
- Why do I need this test?
- Can it show whether the cancer has spread?
- Does every prostate cancer patient need a PSMA PET scan?
- Can the results change my treatment plan?
In recent years, Ga-68 PSMA PET/CT has become one of the most important advances in the evaluation of prostate cancer.
This technology allows physicians to assess the extent of prostate cancer with much greater accuracy and helps create more personalized treatment plans.
What Is PSMA?
PSMA stands for Prostate-Specific Membrane Antigen, a protein that is found in higher concentrations on the surface of many prostate cancer cells.
PSMA-targeted imaging agents are designed to attach to these cells, making them easier to detect during imaging studies.
As a result, prostate cancer cells can be visualized with a high degree of sensitivity.
What Is Ga-68?
Gallium-68 (Ga-68) is a radioactive tracer used for medical imaging.
When a PSMA-targeting molecule is labeled with Ga-68 and injected into a vein, it can bind to prostate cancer cells throughout the body.
PET/CT imaging can then identify areas where the tracer has accumulated, helping physicians locate prostate cancer cells.
For this reason, the examination is commonly referred to as:
- Ga-68 PSMA PET
- Gallium-68 PET
- PSMA PET
- PSMA PET/CT
How Does Ga-68 PSMA PET/CT Work?
During the procedure, a small amount of a Ga-68 PSMA tracer is injected intravenously.
After an appropriate waiting period, PET/CT imaging is performed.
This allows detailed evaluation of:
- The prostate region
- Lymph nodes
- Bones
- Liver
- Lungs
- Other organs
The goal is to determine the location and extent of prostate cancer as accurately as possible.
Why Is Ga-68 PSMA PET/CT Ordered?
Not every prostate cancer patient requires this examination.
It is most commonly recommended in situations such as:
- Intermediate-risk prostate cancer
- High-risk prostate cancer
- High Gleason scores
- Elevated PSA levels
- Suspicious lymph nodes
- Rising PSA after treatment
The primary objective is to assess whether the disease has spread beyond the prostate.
Why Is It Important Before Surgery?
One of the most important questions in prostate cancer management is:
Is the cancer confined to the prostate, or has it spread outside the gland?
Ga-68 PSMA PET/CT can provide valuable information to answer this question.
In particular, it may help detect:
- Lymph node metastases
- Bone metastases
- Distant organ involvement
These findings can directly influence treatment decisions.
Can It Detect Every Prostate Cancer Lesion?
No.
Although Ga-68 PSMA PET/CT is one of the most sensitive imaging tools currently available for prostate cancer, no imaging test is perfect.
Very small cancer deposits may occasionally remain undetected.
In addition, not every area of tracer uptake necessarily represents cancer.
For this reason, results should always be interpreted in conjunction with:
- PSA levels
- Multiparametric prostate MRI findings
- Biopsy results
- Clinical evaluation
What Does a Negative PSMA PET/CT Result Mean?
This is a common question among patients.
A negative or “clean” Ga-68 PSMA PET/CT scan generally indicates that no obvious spread of prostate cancer outside the prostate has been detected.
This is usually considered a favorable finding.
However, microscopic cancer cells may still be below the detection limits of current imaging technology.
Therefore, imaging results should always be interpreted within the broader clinical context.
Why Might It Be Ordered After Surgery or Radiation Therapy?
Following robotic radical prostatectomy or radiation therapy, some patients may experience a rise in PSA levels.
This situation is known as biochemical recurrence.
In such cases, Ga-68 PSMA PET/CT is frequently used to:
- Identify the location of recurrence
- Determine the extent of disease
- Guide the most appropriate treatment strategy
Can Ga-68 PSMA PET/CT Change the Treatment Plan?
Yes.
In some patients, PSMA PET/CT findings can significantly alter treatment decisions.
For example:
- Surgical planning may change
- Pelvic lymph node dissection may be considered
- Radiation therapy fields may be modified
- Systemic treatments may become necessary
For this reason, PSMA PET/CT has become an important component of çağdaş prostate cancer management.
Is Ga-68 PSMA PET/CT a Safe Examination?
In general, yes.
Ga-68 PSMA PET/CT is widely used around the world and is considered a safe imaging technique.
Specific preparation and post-procedure instructions may vary between imaging centers, so patients should always follow the recommendations provided by their healthcare team.
The Role of Ga-68 PSMA PET/CT in Çağdaş Prostate Cancer Care
In recent years, Ga-68 PSMA PET/CT has become a key tool for both staging and restaging prostate cancer.
This technology allows:
- More accurate assessment of disease extent
- Better treatment selection
- More personalized patient care
- Improved clinical decision-making
As a result, it has transformed the way prostate cancer is evaluated and managed.
Conclusion
Ga-68 PSMA PET/CT is one of the most advanced imaging techniques currently available for the staging and follow-up of prostate cancer.
Particularly in patients with intermediate- and high-risk disease, it can provide valuable information regarding whether the cancer has spread beyond the prostate.
If your physician has recommended a Ga-68 PSMA PET/CT scan, this examination may help ensure a more accurate assessment of your disease and contribute to the development of the most appropriate treatment plan for your individual situation.
Assoc. Prof. Dr. Serdar Yalçın
Urology Specialist
Prostate Cancer • Ga-68 PSMA PET/CT • Robotic Urology • Urologic Oncology • Personalized Cancer Care